Tinnitus implant: tinnitus and cochlear implantatio
- Conditions
- tinnitus, bilateral hearing loss, bilateraal gehoorverlies
- Registration Number
- NL-OMON23880
- Lead Sponsor
- Department of Otorhinolaryngology and Head & Neck Surgery University Medical Center Utrecht, Utrecht, The Netherlands
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 50
Patients aged 18 or older
- Seeking help for tinnitus
- Subjective tinnitus
- Tinnitus Functional Index (TFI) > 32
- Tinnitus duration > 1 and tinnitus stability > 6 months
- Hearing level (measured with a maximum of 3 months before eligibility assessment):
> Audiometry (Pure Tone Average (PTA) at 0.5,1,2,4 kHz): bilateral threshold between 50 and < 75 dB
> Hearing threshold stability (PTA < 5 dB change for 1 year in each ear)
- Becks Depression Inventory (BDI) <19
- Health status allows general anesthesia and surgery for the cochlear implantation
- Failure of regular tinnitus care (e.g. psychological or sound therapy)
- Dutch language proficiency
- Willingness and ability to participate in all scheduled procedures outlined in the protocol
- Able to understand and sign informed consent
- Patient primary seeking help for non-tinnitus hearing problems
- Abnormal cochlear anatomy (i.e. ossification)
- Comorbidity with an expected survival of less than five years based on medical history as assessed by clinician and in electronical patient file
- Additional handicaps that would prevent participation in the evaluations
- Presence of any instable psychiatric condition within 1 year before start of the study
- Unrealistic expectations on the part of the patient regarding the possible benefits, risks and limitations that are inherent to the procedure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference of the Tinnitus Functional Index (TFI) between the intervention group (CI group) at 6 months after cochlear implantation (CI) and the control group at 6 months after randomization
- Secondary Outcome Measures
Name Time Method Secondary objectives are to assess change in:<br>- Beck's Depression Index (BDI)<br>- Handicap Anxiety and Depression Scale (HADS)<br>- Electrocochleography (ECochG)<br>- Pure tone audiometry at 0.25, 0.5, 1, 1.5, 2; 4 kHz<br>- Speech, Spatial and Qualities of hearing scale (SSQ)<br>- EuroQoL5D<br>- Glasgow Benefit Inventory (GBI)<br>- Clinical Global Impression (CGI)<br>- Tinnitus severity Visual Analogue Scale (VAS)<br>- Tinnitus pitch and loudness matching<br>- Speech recognition test in quiet and noise<br>The usage of CI and the hearing environment on daily average will be logged from the sound processor.